In memoriam: Joel S. Bennett
, a blood researcher at the University of Pennsylvania, died June 21, of pancreatic cancer. He was 78.
Bennet was born in 1942 to Marvin and Rhoda Bennett and grew up in Southfield, Michigan. He graduated from the University of Michigan with a premed bachelor’s degree in 1963 and a medical degree from the University of Michigan Medical School in 1967.

After earning his M.D., Bennett went to University of Pennsylvania for a residency in internal medicine and a fellowship in hematology–oncology. Outside of briefly serving as a physician in the U.S. Air Force, Bennett remained a member of Penn’s medical and academic community for over 40 years.
Bennett’s research focused on understanding the biophysical and molecular interactions of tiny blood cells called platelets. He was the first to discover that a protein produced by the liver called fibrinogen binds platelets. This binding results in clumping and accumulation of platelets that is important for clotting and can play a role in heart attacks or strokes.
This discovery and Bennett’s other research into platelet biology contributed to the development of drugs that block platelet aggregation, commonly known as blood thinners. Today these drugs are critical to preventing blood clots in certain at-risk patients.
Bennett received various awards in recognition of his work, including the Ernest Beutler Prize from the American Society of Hematology, the society’s highest honor. He was also recognized by the Association of American Physicians and the American Society for Clinical Investigation.
According to in The Philadelphia Inquirer, Bennett is remembered by his colleagues for his scientific acumen, devotion to his patients and dedication as an educator.
Bennett is survived by his wife, Evelyn; three sons, Joe, David and Andrew Bennett; two daughters, Lisa Bennett and Lisa Dunn; a brother and sister; and nine grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.